WO2024180476 - SOLID STATE FORMS OF ANLOTINIB AND PROCESS FOR PREPARATION THEREOF
National phase entry is expected:
Publication Number
WO/2024/180476
Publication Date
06.09.2024
International Application No.
PCT/IB2024/051869
International Filing Date
27.02.2024
Title **
[English]
SOLID STATE FORMS OF ANLOTINIB AND PROCESS FOR PREPARATION THEREOF
[French]
FORMES À L'ÉTAT SOLIDE D'ANLOTINIB ET LEUR PROCÉDÉ DE PRÉPARATION
Applicants **
ASSIA CHEMICAL INDUSTRIES LTD.
Inventors
KORDIC, Lorena
Priority Data
63/448,368
27.02.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1882 | |
| EPO | Filing, Examination, Granting | 8107 | |
| Japan | Filing, Examination, Granting | 2000 | |
| South Korea | Filing, Examination, Granting | 1754 | |
| USA | Filing, Examination, Granting | 6540 |
Total:
20,283
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Solid state Form of Anlotinib processes for preparation thereof, and pharmaceutical compositions thereof are described. (Formula I)[French]
L'invention concerne la forme à l'état solide d'anlotinib, des procédés de préparation associés, et des compositions pharmaceutiques correspondantes. (Formule I)